Health Catalyst, Inc. (HCAT) Cash Flow Statement
Health Catalyst, Inc. (HCAT) generated $28.2M of operating cash flow over the twelve months to 2026-06-30, spent $20.3M on capital expenditure and had free cash flow of $7.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HCATHealth Catalyst, Inc.Follow HCAT — free
—
Price chart with a free account
- Market cap
- 127.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -32.2 | -26.1 | -23.1 | -35.3 | -33.1 | 14.6 | 0.7 | 28.2 | |
| Capital expenditure | 2.0 | 7.8 | 17.1 | 15.2 | 13.2 | 15.9 | 20.7 | -20.3 | |
| Free cash flow | -34.2 | -33.9 | -40.2 | -50.4 | -46.3 | -1.3 | -20.0 | 7.9 | |
| Share repurchases | 0.0 | 0.0 | 0.0 | 8.4 | 1.8 | 0.0 | 5.0 | — | |
| Stock-based compensation | 17.8 | 38.0 | 65.1 | 72.1 | 55.8 | 40.1 | 27.0 | — |
USD millions · SEC XBRL
Health Catalyst, Inc. — questions
- What is Health Catalyst, Inc.'s operating cash flow?
- $28.2M over the twelve months to 2026-06-30.
- How much does Health Catalyst, Inc. spend on capital expenditure?
- $20.3M over the twelve months to 2026-06-30.
- What is Health Catalyst, Inc.'s free cash flow?
- $7.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Health Catalyst, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.